AGÕæÈ˹ٷ½

STOCK TITAN

Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced today that the company’s management will host an informational webinar on Bio-Rad’s Droplet Digital� PCR (ddPCR�) product portfolio on Tuesday, August 26, 2025, at 10:00 AM Pacific Time (1:00 PM Eastern Time). The event will include a presentation followed by a Q&A session with analysts hosted by Bio-Rad’s President and Chief Operating Officer Jon DiVincenzo and Chief Financial Officer Roop K. Lakkaraju.

To participate, dial (800) 715-9871 within the U.S. or (+1) (646) 307-1963 outside the U.S., access code: 9562470. A live of the event, and the accompanying slide presentation, will also be available in the "Investor Relations" section of the company’s website under "Events & Presentations" at . A replay of the webcast will be available for up to a year.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,500 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.

Investor Contact:

Edward Chung, Investor Relations

510-741-6104

[email protected]

Media Contact:

Anna Gralinska, Corporate Communications

510-741-6643

[email protected]

Source: Bio-Rad Laboratories, Inc.

Bio Rad Labs Inc

NYSE:BIO

BIO Rankings

BIO Latest News

BIO Latest SEC Filings

BIO Stock Data

6.81B
18.65M
15.56%
84.59%
3.08%
Medical Devices
Laboratory Analytical Instruments
United States
HERCULES